Literature DB >> 33384054

Finding the right balance between efficacy and tolerability for TB treatment: the search continues.

A K J Maug1, M A Hossain1, M Gumusboga2, T Decroo3, W Mulders2, S Braet2, J Buyze2, D A Jiménez2, C Schurmans2, N Herssens2, T Demeulenaere4, L Lynen2, B C de Jong2, A Van Deun5.   

Abstract

Entities:  

Year:  2021        PMID： 33384054     DOI： 10.5588/ijtld.20.0575

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  1 in total

1.  Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings.

Authors:  Armand Van Deun; Valentin Bola; Rossin Lebeke; Michel Kaswa; Mohamed Anwar Hossain; Mourad Gumusboga; Gabriela Torrea; Bouke Catharine De Jong; Leen Rigouts; Tom Decroo
Journal:  JAC Antimicrob Resist       Date:  2022-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.